Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Medical Genetics and Applied Genomics, |
RCV002464971 | SCV002759340 | uncertain significance | Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome | 2022-12-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004067550 | SCV004868472 | uncertain significance | Inborn genetic diseases | 2023-11-21 | criteria provided, single submitter | clinical testing | The c.2048A>G (p.N683S) alteration is located in exon 11 (coding exon 11) of the SPATA5 gene. This alteration results from a A to G substitution at nucleotide position 2048, causing the asparagine (N) at amino acid position 683 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |